doi: 10.3389/fimmu.2024.1386607 Received 15 February 2024 Accepted 11 April 2024 Published 03 June 2024 Volume 15 - 2024 Edited by Aleksandra Piechota-Polanczyk, Jagiellonian University, Poland Reviewed by Pawel Zalewski, Nicolaus Copernicus University in Toru, Poland Shuhei Sakakibara, Jikei University of Health Care Sciences, Japan Lorenzo Lorusso, ASST Lecco, Italy Updates Copyright 2024 Arron, Marsh, Kell, Khan, Jaeger and Pretorius
Food and Drug Administration (FDA) for safety, efficacy, or any therapeutic purpose
Research: Beghi, Ettore, et al
CJC-1295 and Ipamorelin have meaningful human data showing restoration of growth hormone pulse patterns, with downstream effects on body composition and sleep quality